Masks Against Surface-Scanning for Radiation Therapy Immobilisation in Head and Neck Cancer (MASSC) (MASSC)
Head and Neck Neoplasm
About this trial
This is an interventional other trial for Head and Neck Neoplasm focused on measuring Radiotherapy, Radiotherapy, Image-Guided
Eligibility Criteria
Inclusion Criteria:
- Patients ≥ 18 years old
- Histologically confirmed head and neck cancer.
- Patients treated with radiotherapy (RT) as primary treatment.
- An Eastern Cooperative Oncology Group (ECOG) Performance Status grade of 0-1 as defined in Appendix 3.
- Each subject must sign an informed consent form (ICF) indicating that he understands the purpose of and procedures required for the study and is willing to participate in the study.
- Patients must be willing to comply with treatment plan and other study procedures
Exclusion Criteria:
- Patients with significantly altered mental status or with psychological, familial, sociological or geographical condition potentially hampering compliance with the study.
- Patients who cannot stay still during fraction because of a disorder (e.g. Parkinson's disease)
Sites / Locations
- GZA Ziekenhuizen campus Sint-AugustinusRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
Starting with closed mask
Starting with open mask
Starting with no mask
Patient 1-8, receiving radiotherapy for head and neck cancer in this study. Patients will receive 35 fractions of radiotherapy in total. For the first 5 fractions these patients will receive radiotherapy using a closed mask. For the next 5 fractions these patients will receive radiotherapy using an open mask. For the 5 fractions after that these patients will receive radiotherapy using no mask. This schedule repeats for the rest of their treatment.
Patient 9-16, receiving radiotherapy for head and neck cancer in this study. Patients will receive 35 fractions of radiotherapy in total. For the first 5 fractions these patients will receive radiotherapy using an open mask. For the next 5 fractions these patients will receive radiotherapy using no mask. For the 5 fractions after that these patients will receive radiotherapy using a closed mask. This schedule repeats for the rest of their treatment.
Patient 17-24, receiving radiotherapy for head and neck cancer in this study. Patients will receive 35 fractions of radiotherapy in total. For the first 5 fractions these patients will receive radiotherapy using no mask. For the next 5 fractions these patients will receive radiotherapy using a closed mask. For the 5 fractions after that these patients will receive radiotherapy using an open mask. This schedule repeats for the rest of their treatment.